Introduction
Rod bipolar cells (RBCs) are key retinal interneurons in the rod visual pathway that receive light-driven synaptic input from rod photoreceptors and drive retinal output via synapses onto AII amacrine cells. RBCs serve different visual functions depending on luminance conditions. When dark adapted, they are able to transmit single photon responses [1, 2] , allowing for useful vision in starlight. RBCs are also able to transmit contrast changes against dim background light [3, 4] , and have recently been shown to influence vision in daylight [5] . Little is known about how RBCs adjust their sensitivity and gain to transition between these modes, but compelling evidence suggests phosphorylation by protein kinase C-alpha (PKCα) may play a role.
PKCα is a serine/threonine protein kinase that undergoes calcium-dependent translocation from the cytosol to the plasma membrane, where it is activated upon binding to diacylglycerol (DAG). It is a powerful modulator of signal transduction pathways and is so abundant in RBCs that it is used as a cell marker to identify RBCs with retinal immunofluorescence [6] [7] [8] . The light response of RBCs is reflected in the b-wave of the dark-adapted electroretinogram (ERG), and comparison of ERGs from wild type (WT) and PKCα knockout (PKCα-KO) mice reveal that genetic deletion of PKCα results in increases in both amplitude and duration of the scotopic b-wave [9, 10] . This effect is particularly dramatic at brighter light intensities, suggesting that PKCα modulates the light response in an intensity-dependent manner. If the effect of PKCα on the light response is due to its kinase activity, then RBC proteins phosphorylated by PKCα are also likely to be involved in the modulation of RBC activity.
We used a multiplexed tandem mass tag (TMT; Thompson et al., 2003 ) mass spectrometry-based phosphoproteomics approach to identify proteins that were differentially phosphorylated between WT and PKCα-KO retinas in order to gain insight into the biochemical mechanisms and pathways that mediate the effect of PKCα in RBCs. Phosphopeptide abundance is expected to be dynamic, so TMT acquisition methods that have improved accuracy and wider dynamic ranges are necessary [12] . The larger number of replicates available with high-resolution instruments and TMT tags require improved data normalization and statistical testing methods, and we have successfully applied analysis techniques developed for large-scale protein expression studies [13] to phosphopeptide abundance data. Since PKCα-dependent changes in protein phosphorylation may be due to changes in total protein abundance, we also identified proteins that were differentially expressed between WT and PKCα-KO retinas.
Experimental Procedures
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For quantification of immunofluorescence ( Figure 2C ), we used retina sections from 4 WT and 3 TRPM-1-KO mice, each with 4 technical replicates. For the multiplexed TMT mass spectroscopy experiments, we used 4 WT and 5 PKCa-KO mice. The 5 x 5 study design (one WT sample was lost) was the maximum number of samples accommodated by 10-plex TMT. For both total protein and phosphopeptide experiments, all nine samples were pooled after isobaric labeling and run simultaneously to reduce variability between samples. The statistical tests used are described within the Statistical analysis of differential expression section.
Animals
All studies were approved by the Institutional Animal Care and Use Committee at Oregon Health and Science University. Wild type mice used were C57BL/6J (Jackson Laboratory; Bar Harbor, ME, USA; Cat# 000664). The PKCa-KO mouse strain was B6;129-Pkrca tm1Jmk /J (Jackson Laboratory; Cat# 009068; [10] ). The TRPM1-KO mouse strain was TRPM1 tm1Lex (Texas A&M Institute of Genomic Medicine; College Station, TX, USA; [14] ).
PKCα activation by PMA treatment for immunoblotting or immunofluorescence
Freshly dissected retinas from WT and PKCα-KO mice were incubated at 37°C in 1 μM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich; St. Louis, MO, USA; Cat# P8139) diluted in bicarbonate buffered Ames medium (US Biological Life Sciences; Salem, MA, USA; Cat# A1372-25) for 0 min, 15 min, 30 min, or 60 min. The retinas were then washed three times with Ames medium before being either fixed for cryo-sectioning or processed for western blotting. Torrance, CA, USA; Cat# 4583) and frozen. Sections were cut at 25 μm thickness on a cryostat and mounted onto glass slides, then air dried and stored at -20° C. Thawed retina sections were blocked at room temperature for 1 hr in Antibody Incubation Solution (AIS: 3% normal horse serum, 0.5% Triton X-100, 0.025% NaN3 in PBS). The sections were then incubated in primary antibody diluted in AIS for 1 hr at room temperature. After washing with 3x with PBS, the sections were incubated for 1 hr at room temperature in secondary antibody diluted 1:1000 in AIS. The slides were washed again 3x in PBS and coverslips applied with Lerner Aqua-Mount (Thermo Scientific; Cat# 13800).
Primary antibodies used for immunofluorescence were the same as used for immunoblotting unless indicated: rabbit anti-PKC motif phosphoserine [(R/KXpSX(R/K)] MultiMab mAb mix; 1:250), rabbit anti-PKCα (1:5000; Sigma-Aldrich; Cat# P4334), mouse anti-PKCα clone MC5 (1:5000; Sigma-Aldrich; Cat# P5704), rabbit anti-Borg4 (1:500), rabbit anti-5T4 (1:500;), rabbit anti-NHERF1 (1:100). Secondary antibodies used were anti-rabbit-AF488 (1:1000; Jackson ImmunoResearch Labs; West Grove, PA, USA; Cat# 11-545-144) and anti-mouse-Cy3 (1:1000
Jackson ImmunoResearch Labs; Cat# 115-165-003).
Scanning confocal imaging
Confocal immunofluorescence images were taken with a Leica TCS SP8 X confocal microscope (Leica; Wetzlar, Germany) using a Leica HC PL APO CS2 63x/1.40 oil immersion objective (Leica; Cat#15506350) and Leica HyD hybrid detectors, or with an Olympus Fluoview 1000 microscope (Olympus; Tokyo, Japan) using a 60x/1.42 oil immersion objective. Laser lines used were AF488 (499 nm), and Cy3 (554 nm). Detection windows used were AF488 (509-544nm) and Cy3 (564-758) nm. Brightness and contrast were adjusted using Olympus Fluoview software, Leica LAS X software, or ImageJ [15, 16] .
Preparation of retinas for TMT analysis
To maximize the difference between groups, retinas from wild type (n = 4) and PKCα-KO (n = 5) mice were extracted and treated for 1 hour at 37°C with 1 μM PMA diluted in bicarbonate removed by centrifugation at 16,000 x g for 10 min.
Peptides were purified by solid phase extraction using 1 cc (50 mg) Waters Sep-Pak Vac tC18 cartridges (Waters Corporation; Milford, MA, USA; Cat# WAT054960). Briefly, the cartridges were conditioned twice with 1 mL acetonitrile (ACN) and twice with 300 µL of 50% ACN/0.5% acetic acid, then equilibrated twice with 1 mL 0.1% TFA. The samples were loaded and passed through the bed, then were washed twice with 1 mL 0.1% TFA followed by 200 µL of 0.5% acetic acid. Finally, the samples were eluted twice with 500 µL of 50% ACN/0.5% acetic acid. Peptide concentrations were determined using the Pierce Quantitative Colorimetric Peptide Assay (Thermo Scientific; Cat# 23275). Approximately 300 µg of peptide was recovered from each digest. Fifteen µg of each sample was reserved for TMT analysis of total protein abundance, and the remainder was used for the phosphopeptide enrichment experiment.
Phosphopeptide enrichment
Phosphopeptides were enriched following previously described methods [17, 18] The enriched phosphopeptides were then purified by solid phase extraction using UltraMicro Spin columns (The Nest Group Inc.; Southborough, MA, USA). The dried phosphopeptides were resuspended in 60 µL 1% TFA and the pH was tested to ensure the samples were acidic. The columns were conditioned three times with 100 µL 80% ACN/0.1% TFA and equilibrated three times with 50 µL of 0.1% TFA. The samples were loaded and passed through the columns three times, washed three times with 25 µL of 0.1% TFA, eluted three times with 50 µL 80% ACN/0.1% formic acid, and dried by vacuum centrifugation before TMT labeling.
TMT labeling and mass spectrometric analysis
In preparation for TMT labeling, nine dried unfractionated peptide samples (4 WT and 5 KO) and nine phosphopeptide enriched samples (4 WT and 5 KO) were dissolved in 25 µL of 100 mM triethylammonium bicarbonate buffer, and TMT 10-plex reagents (Thermo Scientific; Cat# 90110) were dissolved at a concentration of 15 µg/µL in anhydrous ACN. Each of the samples was then labeled by adding 12 µL (180 µg) of an individual TMT reagent, followed by shaking at room temperature for 1 hr. Two µL of each of the nine labeled samples in each group were pooled, and 2 µL of 5% hydroxylamine was added. The samples were incubated for 15 min, dried by vacuum centrifugation, dissolved in 21 µL of 5% formic acid, and peptides were analyzed by a single 2-hour LC-MS/MS method using an Orbitrap Fusion as described below. The run was performed to normalize the total reporter ion intensity of each multiplexed sample and to check labeling efficiency. After the normalization and efficiency run, the remaining unmixed samples were then quenched by the addition of 2 µL 5% hydroxylamine, then combined in adjusted volumes to yield equal summed reporter ion intensities during the subsequent two-dimensional LC/MS.
Following volume-based normalization, the combined samples were dried by vacuum centrifugation, and TMT-labeled samples were reconstituted in 20 µL water. The reconstituted peptides were separated by two-dimensional nano reverse-phase liquid chromatography (Dionex NCS-3500 UltiMate RSLCnano UPLC) EasySpray NanoSource (Thermo Scientific), ionized using an EasySpray NanoSource (Thermo Scientific), and SPS MS3 data acquired with an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). The liquid chromatography details and mass spectrometer settings were as previously described [13] with the modification that nonenriched peptides were eluted from the first dimension high pH column using sequential injections of 20 µL volumes of 14, 17, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 50 , and 90% ACN in 10 mM ammonium formate, pH 9, and enriched phosphopeptides were eluted by sequential 20 µL injections of 4, 6, 8, 10, 12, 18, 20, 22, 25, 30 , and 60% ACN in 10 mM ammonium formate, pH 9.
TMT data analysis
The binary instrument files were processed with Proteome Discoverer version 1. 
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The data from the phosphopeptide enrichment experiment was searched with additional variable modifications of +79.9799 on serine, threonine, or tyrosine residues, and only peptides with q < 0.01 were accepted. The phosphorylation site localization node phosphoRS [21] was configured after the search node in Proteome Discoverer. Phosphorylation enrichment experiments are peptide centric, so data aggregation was done differently than for protein expression. Peptide sequences were aggregated by summing reporter ion intensities within each channel to reduce variance and increase statistical power. All PSMs assigned to the same base peptide sequence were aggregated in the same modification state, which was determined by integral peptide MH+ mass (the peptide in a 1+ charge state). Localization information from phosphoRS was simplified to the same number of top probabilities as the number of phosphorylation modifications present in the peptides. The reporter ion intensities from the combined reports were used for differential expression (DE) testing as described below. Any contaminant protein matches were excluded from further analysis. Minimum intensity filtering and zero replacement was done similarly to the total protein analysis.
Statistical analysis of differential expression
For immunofluorescence quantification, data are represented in text as the mean ± SEM and p-values were calculated using an unpaired t-test.
For TMT data, the table of non-contaminant reporter ion intensities for proteins or for aggregated phosphopeptides were exported to tab-delimited files and imported into R (https://www.r-project.org) for statistical analysis using the edgeR [22] [23] [24] Bioconductor package.
Normalization was done using a "library size" factor and the trimmed mean of M-values normalization [25] function in edgeR was used to correct for sample loading and compositional bias. DE testing was performed pairwise using the exact test with Benjamini-Hochberg multiple testing corrections [26] . The results from edgeR analyses were exported and added to the combined data summaries. Annotation information was added from Uniprot using a script available at https://github.com/pwilmart/annotations.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository [27] , with the dataset identifier PXD012906.
Results
RBC dendrites are major sites of light-dependent PKCα phosphorylation
To visualize sites of PKCα phosphorylation in the retina, we used a monoclonal antibody mix that binds to canonical PKC substrate motifs containing a phosphorylated serine (PKC motif p-serine). Anti-PKC motif phosphoserine immunofluorescence between wild type and PKCα-KO retina sections indicates that RBC dendrites are the main sites of PKCα phosphorylation in the mouse retina ( Figure 1A and B). The small immunofluorescent puncta in the outer plexiform layer (OPL) are presumptive RBC dendrites, whereas the larger patches of phosphoserine immunofluorescence (arrows) are associated with cone pedicles. The small immunofluorescent puncta are visible throughout the wild type OPL but are greatly reduced in intensity in the PKCα-KO retina, while immunofluorescence corresponding to cone pedicles is unchanged. These results suggest that PKCα phosphorylates targets in RBC dendrites of wild type adult mice, and that a different PKC isoform phosphorylates targets associated with cone pedicles.
To examine whether PKCα activity is light-dependent, we used a conformation-dependent monoclonal PKCα antibody which binds an epitope in the hinge region of PKCα that is inaccessible in the inactive state [28] . Retina sections from light-adapted and dark-adapted mice were double-labeled with the conformation-specific antibody (anti-PKCα-A) and a non- Conventional PKC isoforms, including PKCα, require calcium for activation [29] . In RBC Figure 3A) demonstrating that PMA treatment increases differential phosphorylation between WT and PKCα-KO retinas. To identify sites of PMA-activated PKC phosphorylation in the wild type retina, PKC motif phosphoserine immunofluorescent labeling was performed on retina sections made from PMA-treated, light-adapted WT retinas. PMA incubation resulted in an increase in PKC motif phosphoserine immunofluorescence in presumptive RBC dendritic tips ( Figure 3B ).
Differential protein abundance in wild type and PKCα-KO retina
To identify retinal proteins whose expression is dependent on PKCα, four wild type and five PKCα-KO retinas were incubated with PMA for an hour immediately after dissection and then proteins can be seen in Figure 5C . The sample-to-sample reproducibility of the protein abundance experiment was excellent: the WT samples had a median coefficient of variance (CV) of 11.4%, the KO samples had a median CV of 15.5%, and the independent CV was 13.5%. Ninety-five percent of the expression changes were less than 1.25-fold different (S2 -Total Protein and
Phosphopeptide Statistical Testing).
Differential protein phosphorylation between wild type and PKCα-KO retina
To examine differences in protein phosphorylation between wild type and PKCα-KO retinas, phosphopeptides were enriched from the same retinal extracts used above (described in the Methods), and phosphopeptide abundance was analyzed by multiplexed TMT mass spectroscopy. Peptide identification was performed with Proteome Discoverer using SEQUEST and Percolator, and phosphorylation localization was performed using phosphoRS. Results files were exported for post processing (filtering and aggregation) using an in-house Python script (PD1.4 TMT phospho processer.py available at https://github.com/pwilmart/PAW pipeline). The aggregated phosphopeptide reporter ion data was tested for differential expression using edgeR with multiple testing corrections, and phosphopeptides were grouped into significance groups based on differential expression FDR as described for total proteins.
We identified 1137 distinct phosphopeptides in wild type or PKCα-KO retina lysates phosphoserines at peptide S6 and S8 (13-fold increase), and a singly-phosphorylated peptide with just phosphorylated peptide S8 (2.8-fold increase). These two serine residues correspond to S422 and S424 in the C-terminal intracellular tail of TPBG ( Figure 7C ).
Grouping of significant protein and phosphoprotein results by biological function
Proteins identified in the total protein abundance ( Figure 8A ) and phosphoprotein abundance ( Figure 8B ) experiments were grouped into broad categories based on general biological function annotations added from Uniprot (https://github.com/pwilmart/annotations.git).
PKCα-KO resulted in differential expression of proteins and phosphoproteins involved in many aspects of cellular physiology, particularly cytoskeletal rearrangement and vesicle trafficking (15 proteins), transcriptional regulation (8 proteins), and homeostasis and metabolism (5 proteins).
Localization of the major PKCα-dependent phosphoproteins in the mouse retina
We used immunoblotting and immunofluorescence confocal microscopy to examine the presence of the three most prominent PKCα-dependent phosphoprotein hits in the wild type retina: BORG4, NHERF1, and TPBG. Immunoblotting for BORG4 shows a distinct band at 38 kDa ( Figure 9A ) in agreement with the predicted molecular weight of BORG4.
Immunofluorescence double-labeling of retina sections for BORG4 and PKCα shows punctate BORG4 labeling in the outer plexiform layer (OPL), but the BORG4 puncta are not strongly colocalized with PKCα ( Figure 9B ). This is consistent with labeling of either RBC or horizontal cell dendritic tips, as they are closely apposed to one another within the rod spherule invagination [32, 33] . BORG4 immunofluorescence was also detected in nuclei in the inner nuclear layer (INL) and ganglion cell layer.
Immunoblotting of retinal proteins for NHERF1 detected a strong band at ~50 kDa, the predicted molecular weight of NHERF1 ( Figure 9C ). Immunofluorescent labeling of retina sections revealed NHERF1 immunoreactivity at the level of the photoreceptor inner segments and in the retinal pigment epithelium (RPE; Figure 9D) . It was not possible to determine whether NERF1 at the level of the inner segments is due to its presence in the photoreceptors themselves or the apical microvilli of the RPE, which surround the photoreceptor outer and inner segments. No NHERF1 immunofluorescence was seen in the synaptic layers of the retina.
Immunoblotting of retina lysate for TPBG labels a broad band centered around 72 kDa ( Figure 9E ). This is higher than the predicted molecular weight of 42 kDa, but is consistent with extensive glycosylation of TPBG [34] . Immunofluorescent localization of TPBG revealed strong immunoreactivity in the OPL as well as in large synaptic terminals at sublamina 5 of the inner plexiform layer (IPL; Figure 9F ). In the OPL, TPBG labeling co-localizes with PKCα in RBC 
Discussion
RBCs are able to modulate their responses to changing light conditions and evidence suggests this process is regulated in part by PKCα [9, 10, 37] . The transient physiological effect of PKCα on the RBC dendrites is presumably mediated by its kinase activity, whereby PKCα-dependent phosphorylation changes the activity of downstream proteins. We show that RBC dendrites are the main sites of light-and PKCα-dependent phosphorylation (Figure 1 ). Using a conformation-specific PKCα antibody and an antibody mix that recognizes phosphorylated PKC substrate motifs, our results suggest that PKCα is active in light-adapted RBC dendrites. In the dark-adapted retina, PKCα is inactive and PKC substrate phosphorylation in the OPL is significantly reduced (Figures 2A and B) . Comparison of light-adapted wild type and PKCα-KO retinas confirmed that phosphorylation in RBC dendrites requires PKCα, and also indicated that phosphorylation in presumed cone bipolar cell dendrites is mediated by a different kinase.
Deletion of TRPM1, a calcium-permeable cation channel responsible for signal transduction in ON-bipolar cell dendrites, also results in a significant reduction in RBC labeling with the conformation-specific PKCα antibody, suggesting that TRPM1-mediated calcium influx during the RBC light response is a primary source of calcium required for PKCα activation in RBC dendrites.
Differential abundance of retinal phosphopeptides between WT and PKCα-KO retinas could potentially be due to altered expression of proteins caused by the deletion of PKCα, and not due to changes in PKCα kinase activity. To identify proteins whose phosphorylation status is dependent on PKCα, but whose expression levels are unaffected, we compared both phosphoprotein and total protein abundance between WT and PKCα-KO mouse retinas using isobaric tagging and mass spectrometry . We identified over 4000 total proteins in either WT or PKCα-KO samples with 23 showing significantly different expression between groups. These proteins can be clustered into several general categories corresponding to biological ontology, most notably proteins involved in regulating cell shape and vesicle transport, transcriptional regulation, and homeostasis and metabolism. PKCα has been implicated in a variety of diverse cell signaling processes, including cell proliferation and morphology, inflammation, and tumorgenesis. Furthermore, PKCα activity has a major impact on gene expression by modulating transcription factors such as CREB, NF-kB, and c-REL [38] . Identifying proteins that show altered expression levels in PKCα-KO mouse retina could be valuable to the examination of many PKCα-dependent functions in RBCs, such as regulation of RBC morphology and development.
To identify RBC proteins that display PKCα-dependent phosphorylation, total retinal phosphopeptides were compared between wild type and PKCα-KO mice using isobaric tagging.
Normalizations and differential expression statistical testing for isobaric tagged phosphopeotides differs from traditional phosphoproteomic experiments where replicate numbers are smaller.
When replicate numbers are greater than one or two, ratios are no longer an appropriate framework for the analysis. We extended our approach of working directly with aggregated reporter ion intensities for differential protein expression to phosphopeptide datasets. Our approach enables the use of robust statistical testing from genomics packages such as edgeR [23] or Limma [39] . The background of unchanged phosphorylation levels in the enrichment experiment, like that of the total protein experiment, was sufficient in these samples to use standard normalization approaches. Our normalizations and statistical testing for both experiments demonstrates that the same analysis steps used for total protein abundance can be successfully applied to the phosphopeptide datasets (S2 -Total Protein and Phosphopeptide
Statistical Testing).
Of over 1100 distinct phosphopeptides identified by multiplex TMT mass spectroscopy, 14 displayed significantly greater phosphorylation in wild type compared to PKCα-KO samples ( Figure 6 ), suggesting their phosphorylation state is dependent on PKCα. These putative PKCα-dependent phosphoproteins may be phosphorylated directly by PKCα or may be phosphorylated by a different kinase whose activity is dependent on PKCα. Only one phosphoprotein, Dnmt3a, showed a significant decrease in abundance in PKCα-KO compared to WT in both the total protein and phosphopeptide experiments ( Figures 5 and 6 ), indicating that reduced abundance of the Dnmt3a phosphopeptide may be due to downregulation of the protein in the KO. Three proteins, BORG4, NHERF1, and TPBG, displayed a particularly striking increase in phosphorylation in wild type compared to PKCα-KO samples (Figures 6 and 7) . Of these proteins, BORG4 and NHERF1
are known substrates of PKCα [40, 41] .
Surprisingly, several of the major PKCα-dependent phosphoproteins identified in this study, including TPBG, do not conform to a strong consensus PKCα substrate motif, in which a phosphorylated serine is flanked by positively charged arginine and lysine residues (Kinexus Database; Vancouver, Canada; http://www.kinexusnet.ca). However, kinase substrate motifs are not always linear, contiguous sequences, but can also be formed structurally by bending of flexible loops that brings positively charged amino acids into proximity to the phosphorylated serine or threonine residues [42] . In the case of TPBG, the cytoplasmic domain is predicted to be unstructured and flexible, possibly allowing the phosphorylated serines at the C-terminal tail (S422 and S424) to be brought close to upstream pairs of lysines and arginines (R384 K385 and K388 and K389) to form a structural PKCα substrate motif. Alternatively, TPBG and other PKCα-dependent non-consensus phosphopeptides may be phosphorylated by a downstream kinase that is dependent on PKCα activity. For example, casein kinase 2 (CK2) is a serine/threonine kinase that is activated by PKCα [43, 44] , and whose consensus substrate motif is a serine flanked by acidic residues (Kinexus Database). Two of the phosphopeptides that showed increased abundance in wild type samples compared to PKCα-KO contain a CK2 substrate motif (TPBG and Mfap2). The same site in Mfap2 has previously been demonstrated to be phosphorylated in vitro. The C-terminals of the NR2B subunit of the NMDA receptor is similar in sequence to the Cterminus of TPBG (LSSIESDV compared to LSSNSDV), and CK2 phosphorylation of the Cterminal serine in NR2B has been demonstrated to regulate trafficking of the receptor [45] . Ten phosphopeptides were more abundant in PKCα-KO samples than in wild type. These are likely to be phosphorylated by kinases that are inhibited by PKCα, such as GSK3 [46, 47] . The consensus substrate motif for GSK3 kinase is a serine residue with a neighboring proline (Kinexus Database), and several of the phosphopeptides that are increased in the PKCα-KO samples fit this motif (examples: Dyn3, Crocc, Map2, and Rtn4).
We used immunofluorescence to localize three phosphoproteins that displayed the greatest differential phosphorylation between wild type and PKCα-KO samples.
Immunofluorescence labeling of BORG4 resulted in bright puncta in the OPL ( Figure 9 ) consistent with BORG4 localization to either RBC or horizontal cell dendrites, as well as immunofluorescence over most nuclei. BORG4 belongs to a protein family (BORG1-5) that bind to the Rho GTPase CDC42 as well as to septins, a family of GTP-binding cytoskeletal proteins that are involved in regulation of cell morphology through modulation of cytoskeletal rearrangement. BORG4 contains an N-terminal CCD42/Rac Interactive Binding Motif (CRIB) and three BORG Homology (BHs) domains that are conserved across all BORG family proteins [48] .
Our proteomics data indicates that the serine residue S64 in BORG4, which is located between BH1 and BH2, is phosphorylated in a PKCα-dependent manner. Phosphorylation of BORG4 S64
has been previously recognized in large-scale analyses experiments of tissue-specific phosphorylation patterns [49, 50] though not in retina. BORG4 and Septin-4 mRNAs have been previously found to be expressed in horizontal cells [51] . Our immunofluorescence labeling of BORG4 in retina resulted in bright puncta in the OPL consistent with BORG4 localization to either RBC or horizontal cell dendrites.
We detected NHERF1 immunofluorescence at the level of the photoreceptor inner segments in the region of the connecting cilia and in the retina pigment epithelium (RPE, Figure   9 ). NHERF1 is a scaffolding protein containing tandem PDZ domains and an Ezrin/Radixin/Moesin Binding (EB) domain. Our detection of strong NHERF1
immunofluorescence in the RPE consistent with previous reports localizing NHERF1 to the RPE apical microvilli [52] . NHERF1 interacts with ezrin to maintain the structure of apical microvilli on epithelia. In the RPE, NHERF1 has been implicated in retinoid recycling [52] through its interactions with CRALBP [53, 54] . PKCα is also expressed in the RPE [55] where it is involved in proliferation and migration [56] , phagocytosis [57] , and melanin production [58] ; however, the specific role of PKCα-mediated phosphorylation of NHERF1 in the RPE is unknown.
Immunofluorescence confocal microscopy localized TPBG immunoreactivity to RBC dendrites and synaptic terminals, as well as to a class of amacrine cells (Figure 9 ). TPBG is a heavily glycosylated type-1 transmembrane protein with a large extracellular N-terminal domain and a short C-terminal intracellular tail. The N-terminal domain contains eight leucine-rich repeats (LRRs) and seven N-linked glycosylation sites. The C-terminal tail ends with the class-1 PDZinteracting motif (S/T C F) SDV [59] , which our proteomics data suggests is phosphorylated in a PKCα-dependent manner. Since phosphorylation of a PDZ-interacting motif typically prevents binding of a PDZ protein [60] , PKCα might be regulating interactions between TPBG and PDZ proteins by stimulating phosphorylation of its C-terminal tail. As an oncofetal antigen, TPBG is present primarily during embryonic development [61, 62] , but is also expressed in many carcinomas (Southall et al., 1990 ). In the adult, TPBG is expressed in the brain, retina, and ovaries [65, 66] . In the embryo and in cancer tissue, TPBG is involved in regulating actin polymerization [67] filopodia formation [68] , and chemotaxis [69, 70] , and its expression in tumors is linked to increased metastatic malignancy and poor survival outcomes in cancer patients [71, 72] . In the adult olfactory bulb, TPBG is required to stimulate the development of input-dependent dendritic arborization and synaptogenesis of newborn granule cells [36, [73] [74] [75] . The role of TPBG in the retina is not yet understood; however, a recent transcriptomic classification of retinal cell types identified TPBG mRNA as being highly enriched in RBCs [35] . This is consistent with our immunofluorescent analysis which localized TPBG to RBC dendrites and synaptic terminals.
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Conclusions
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